Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil hydrochloride for amyotrophic lateral sclerosis
ChiCTR-TRC-14004981Phase 4Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in amyotrophic lateral sclerosis (ALS) and motor neuron disease (MND) comparing Donepezil hydrochloride with Donepezil hydrochloride placebo (2 arms). Primary endpoint: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised. Started Aug 2014; status: recruiting.
02
Drugs
donepezil
03
Conditions
amyotrophic lateral sclerosis (ALS)motor neuron disease (MND)
Beyond the preview
Go deeper on ChiCTR-TRC-14004981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004981.